Abrahmsen Lars B. 4
4 · Aprea Therapeutics, Inc. · Filed Oct 7, 2019
Insider Transaction Report
Form 4
Abrahmsen Lars B.
SVP, Chief Scientific Officer
Transactions
- Award
Stock Option (right to Buy)
2019-10-07+77,630→ 77,630 totalExercise: $15.00Exp: 2029-10-02→ Common Stock (77,630 underlying)
Footnotes (1)
- [F1]Twenty-five percent of these options vest on October 2, 2020, with the remaining options vesting ratably over the following 36 months, subject to the reporting person's continued employment through and including the applicable vesting date and subject to acceleration under certain conditions.